These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 11289486)

  • 1. Recent advances in our understanding of insulin action and insulin resistance.
    Le Roith D; Zick Y
    Diabetes Care; 2001 Mar; 24(3):588-97. PubMed ID: 11289486
    [No Abstract]   [Full Text] [Related]  

  • 2. Insights into insulin resistance and type 2 diabetes from knockout mouse models.
    Kadowaki T
    J Clin Invest; 2000 Aug; 106(4):459-65. PubMed ID: 10953020
    [No Abstract]   [Full Text] [Related]  

  • 3. [Mechanisms of thiazolidinedione derivatives for hypoglycemic and insulin sensitizing effects].
    Sugiyama Y; Murase K; Ikeda H
    Nihon Rinsho; 2000 Feb; 58(2):370-5. PubMed ID: 10707560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An in vivo model for elucidation of the mechanism of tumor necrosis factor-alpha (TNF-alpha)-induced insulin resistance: evidence for differential regulation of insulin signaling by TNF-alpha.
    Cheung AT; Ree D; Kolls JK; Fuselier J; Coy DH; Bryer-Ash M
    Endocrinology; 1998 Dec; 139(12):4928-35. PubMed ID: 9832430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD36, insulin resistance, and coronary heart disease.
    Aitman TJ
    Lancet; 2001 Mar; 357(9257):651-2. PubMed ID: 11247544
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of insulin resistance with peroxisome proliferator-activated receptor gamma agonists.
    Olefsky JM
    J Clin Invest; 2000 Aug; 106(4):467-72. PubMed ID: 10953021
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pioglitazone].
    Kobayashi M; Iwata M; Hiratani K
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():429-37. PubMed ID: 12387029
    [No Abstract]   [Full Text] [Related]  

  • 8. Pioglitazone ameliorates tumor necrosis factor-alpha-induced insulin resistance by a mechanism independent of adipogenic activity of peroxisome proliferator--activated receptor-gamma.
    Iwata M; Haruta T; Usui I; Takata Y; Takano A; Uno T; Kawahara J; Ueno E; Sasaoka T; Ishibashi O; Kobayashi M
    Diabetes; 2001 May; 50(5):1083-92. PubMed ID: 11334412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Insulin signal transduction disorder and development of insulin resistance].
    Huang DM; Lu FE
    Sheng Li Ke Xue Jin Zhan; 2003 Jul; 34(3):212-6. PubMed ID: 14628465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Regulation of insulin receptor function in microdomains].
    Inokuchi J; Kabayama K; Nagafuku M; Sato T
    Tanpakushitsu Kakusan Koso; 2008 Sep; 53(12 Suppl):1552-7. PubMed ID: 21089365
    [No Abstract]   [Full Text] [Related]  

  • 11. [Insulin receptor dysfunction and insulin resistance].
    Maegawa H
    Nihon Rinsho; 2002 Jul; 60 Suppl 7():553-8. PubMed ID: 12238097
    [No Abstract]   [Full Text] [Related]  

  • 12. PPAR-gamma: adipogenic regulator and thiazolidinedione receptor.
    Spiegelman BM
    Diabetes; 1998 Apr; 47(4):507-14. PubMed ID: 9568680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Insulin receptors].
    Capeau J; Magre J; Reynet C; Cherqui G; Caron M; Melin B; Lascols O; Picard J
    Ann Med Interne (Paris); 1990; 141(2):145-55. PubMed ID: 2191616
    [No Abstract]   [Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptor gamma: A key regulator of adipogenesis and systemic insulin sensitivity.
    Spiegelman BM
    Eur J Med Res; 1997 Nov; 2(11):457-64. PubMed ID: 9385114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PPARgamma and the thiazolidinediones: molecular basis for a treatment of 'Syndrome X'?
    Sewter C; Vidal-Puig A
    Diabetes Obes Metab; 2002 Jul; 4(4):239-48. PubMed ID: 12099972
    [No Abstract]   [Full Text] [Related]  

  • 16. Insulin resistance, inflammation, and non-alcoholic fatty liver disease.
    Tilg H; Moschen AR
    Trends Endocrinol Metab; 2008 Dec; 19(10):371-9. PubMed ID: 18929493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Insulin signalization and molecular mechanisms of insulin resistance].
    Kahn CR
    Journ Annu Diabetol Hotel Dieu; 1999; ():125-41. PubMed ID: 10732412
    [No Abstract]   [Full Text] [Related]  

  • 18. Does the mechanism responsible for TNF-mediated insulin resistance involve the proteasome?
    Pallarés-Trujillo J; Carbó N; López-Soriano FJ; Argilés JM
    Med Hypotheses; 2000 Apr; 54(4):565-9. PubMed ID: 10859639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of insulin action.
    Pirola L; Johnston AM; Van Obberghen E
    Diabetologia; 2004 Feb; 47(2):170-84. PubMed ID: 14722654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin receptor structure and function in normal and pathological conditions.
    Becker AB; Roth RA
    Annu Rev Med; 1990; 41():99-115. PubMed ID: 2184752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.